Healthcare ECONOMIST
SEPTEMBER 15, 2021
reduced smoking rates) is having an impact, but another key key question is, what is medical technologies are driving these gains? Is it new surgical techniques, better diagnostics, improved medical devices, or new pharmaceuticals? Across all 8 diseases 56% of the relative value came from pharmaceuticals.
HIT Consultant
SEPTEMBER 17, 2024
The wearable utilizes advanced Acoustic Resonance Therapy (ART) to deliver a non-pharmaceutical treatment for rhinitis, providing relief that is comparable to or better than nasal corticosteroids, without known side effects. What You Should Know: – SoundHealth, Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
FEBRUARY 28, 2024
Hanneman brings over 20 years of experience in the MedTech and pharmaceutical industries. She joins Philips from Stryker, a global medical technology company, where she currently serves as Controller and Head of Financial Planning & Analysis. Hanneman’s Bio/Background Ms. Prior to Stryker, Ms.
HIT Consultant
OCTOBER 16, 2024
– The platform—which includes Honeywell’s TrackWise Quality , Salesforce Life Sciences Cloud , Agentforce, and other solutions—will help pharmaceutical and medical technology companies deliver critical medications and healthcare devices to patients more quickly, safely, and affordably.
Healthcare ECONOMIST
MAY 30, 2023
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medical technologies, particularly in Eastern Europe and developing countries. The abstract is below.
HIT Consultant
AUGUST 30, 2023
AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs. IvorIvor has been in a candidate search for more than 30 years.
Bill Of Health
SEPTEMBER 20, 2022
Dose shortages elevated the role of pharmaceutical executives. Pharmaceutical corporations hoarded technology that could have helped alleviate scarcity. At the end of 2021, Thomas Cueni, the head of an international pharmaceutical trade association, acknowledged that everyone was “ashamed and embarrassed” by the inequity. “We
Expert insights. Personalized for you.
79 
Let's personalize your content